MMS (Miracle Mineral Solution)

The Miracle Mineral Solution (MMS) is a solution of 28% Sodium Chlorite and it is very harmful to the single celled organisms like bacteria, fungi and protozoa. According to some researchers, the Miracle Mineral Solution (MMS) can cure the malaria in just four hours by killing the intracellular pathogenic protozoa by the process of reactive oxygen species mediated respiratory burst. [1] The Sodium chlorite when combined with the oxygen in the body can effectively destroy the microbial organisms without causing any side effects to the host. John Humble is the first man to coin the term Miracle Mineral Solution (MMS) and in his book, he claimed that Miracle Mineral Solution (MMS) can also cure Human Immunodeficiency virus, Birds flu, common cold, and viral hepatitis, some forms of cancer and acne vulgaris which is the common form of pimples. [2] Due to the chemical property that is similar to Reactive Oxygen Species, the bacterial cannot form a resistant gene. The mode of neutralizing or killing the bacteria, viruses and fungi is the respiratory arrest by creating an oxygen demand to the organisms. The science behind the Miracle Mineral Solution (MMS) is simple, yet powerful in which the chlorites are the oxidizing agents that can readily accept the electrons by the chemical reactions, from any of the compounds or the living substances which are called as the “electron donors.” Since most of the pathogenic microorganisms are electron donating mediums, the Miracle Mineral Solution can effectively kill the pathogenic organisms by arresting the respiratory system. Hence, the Miracle Mineral Solution (MMS) is useful to treat most of the diseases that is caused by single celled organisms. The Miracle Mineral Solution (MMS) can also be used as a water purifier due to its anti-microbial property.

After purchasing your Miracle Mineral Solution (MMS), you need to dilute by your own before taking the Miracle Mineral Solution (MMS) and you can prepare the dilution by your own with simple requirements like lemon or with commercial citric acid. Take one part of Miracle Mineral Solution (MMS) and add with one part of citric acid or lemon juice and then with nine parts of sterile water. Then you can store this mixture for the future use. At the Initial dose, Miracle Mineral Solution (MMS) may cause nausea and Gastro-intestinal disturbances in some of the patients and it will be settled down on the time course of the medication. You should take the Miracle Mineral Solution (MMS) in the therapeutic dose as prescribed by a Natural treatment Physician. If you take in the correct dose, you can realize the relief from the disease in some hours and without any side effects.


1. Judith R Lubbers, Sudha Chauhan, Joseph R Bianchine (1981). Controlled Clinical Evaluation of Chlorine Dioxide and Chlorate in Man. Toxicol. Sci. 1 (4): 334-338.

2. Jim Humble (2006). The Miracle Mineral Solution of the 21st Century. Retrieved 2011-08-22.

About Chlamydia

The problem is a condition due to the bacteria Chlamydia trachomatis. It is most generally intimately given.

Causes, occurrence, and possibility factors

Chlamydia illness is the most common std in the U. s. Declares. If perhaps you are people and people with several lovers are at maximum possibility.


As many as 1 in 4 men with chlamydia have no symptoms. In men, chlamydia may generate symptoms just like gonorrhea. Symptoms may include:Burning feeling during urinationDischarge from the member or rectumTesticular tenderness or painRectal eliminate or painOnly about 30% of women with chlamydia have symptoms. Symptoms that may happen in women include:Burning feeling during urinationPainful sex-related intercourseRectal discomfort or dischargeSymptoms of PID, salpingitis, liver organ soreness identical to hepatitisVaginal dischargeSee also: Chlamydia in women

Signs and tests

The analysis of chlamydia illness includes choosing of the urethral discharge in men or cervical secretions in women. If an personal includes in rectal sex-related get in touch with, products from the rear end may also be required. The taste is sent for a neon or monoclonal antibody test, DNA probe analyze, or cellular lifestyle. Some of these testing may also be conducted on pee products.


The regular strategy to chlamydia is medications, such as tetracyclines, azithromycin, or erythromycin.You can get chlamydia with gonorrhea or syphilis, so if you have one std you must be tested for other std’s as well. All sex-related connections should be tested for chlamydia.Sexual lovers must be handled to prevent moving the illness back and forth. There is no significantimmunity following the illness and a person may become regularly contaminated.A follow-up assessment may be done in 4 several weeks to identify if the illness has been handled.

Expectations (prognosis)

Early anti-biotic therapy is incredibly effective and may prevent the progression of long-term problems. Without treatment illness, however, may cause to problems.


Chlamydia attacks in women may cause to soreness of the cervix. In men, chlamydia illness can cause to soreness of the urethra known as urethritis.An untreated chlamydia illness may propagate to the womb or the fallopian pipes, producing salpingitis or pelvic inflamed condition. These circumstances can cause to inability to conceive and improve the chance of ectopic having a baby.If a women is contaminated with chlamydia while expecting, the illness may cause illness in the womb after shipping (late postpartum endometritis). Moreover, the baby may create chlamydia-related conjunctivitis (eye infection) and pneumonia. See: chlamydial pneumonia

Calling your medical appropriate care provider

Call your doctor if you have symptoms and symptoms of chlamydia.Because many people with chlamydia may not have symptoms, intimately dynamic grownups should be tested regularly for the illness.


All intimately dynamic women up through age 25 should be tested annual for chlamydia. All women with new sex-related lovers or several lovers should also be tested.A mutually monogamous sex-related connection with an uninfected associate is one way to prevent this illness. The appropriate use of contraceptives during sexual activity usually stops illness.

Colloidal Silver

The Colloidal Silver is a natural compound with 15 positively charged atoms that are bonded with a protein moiety molecule. The Colloidal Silver is a natural antibiotic that was in the treatment practice for a long time. Colloidal Silver is a potent antibiotic that can effectively kill the microbes including bacteria, viruses, fungi and other protozoa by arresting the respiratory system-specific enzymes. By this process, the microbes will die immediately. The Colloidal Silver is superior to the antibiotics that are currently prescribed by the Physicians. Unlike the new generation antibiotics, the Colloidal Silver never harms the host by suppressing protein synthesis or degrading the key metabolic enzymes. The use of Colloidal Silver as a medicine is stopped by the Physicians in the year of 1938 due to introduction of new generation of Pharmaceutical grade antibiotics. But still the Food and Drug Administration approves the use of the Colloidal Silver as a therapeutic drug and it is classified under the “Pre-1938” drug. [1] Hence it is a medicine approved for the therapeutic use and the medical benefits of Colloidal Silver are researched and well-documented by the Scientific Community.

The Colloidal Silver can be used as a medicine for more than 650 diseases and disorders that includes the treatment of Chlamydia pneumoniae, Chlamydia trachomatis and many more pathogenic microorganisms, dermatitis, dandruff, diabetes, Cancer, lupus, lymphadenitis, fungal and bacterial pneumonia etc. [2]

The usual route of administration of Colloidal Silver is oral route and it is rapidly absorbed by the digestive system that can enable the Colloidal Silver to act immediately up on administration. But the best route for taking the Colloidal Silver is the keeping the Colloidal Silver under the tongue. By this way, the Colloidal Silver is rapidly absorbed by the mucus membrane under the tongue and it can act in the system long lastingly without any side effects. The Colloidal Silver is usually eliminated by the kidneys via urine and by the intestinal system. If you are experiencing recurrent infections, it is better to take the Colloidal Silver in a nutritional dose of 1 – 4 teaspoons/day. It is generally safe and in case untreatable conditions, the Physicians will prescribe you the Therapeutic Dose of Colloidal Silver, in accordance with your weight, height and age. You must not take the Therapeutic dose of Colloidal Silver by your own.

The other medical benefits of Colloidal Silver are: It can be used in case of skin burns, open wounds, cuts, and abrasions, warts reduction and removal, insect bites, eczema like skin rashes and urticaria like skin itching with rashes, antiseptic and deodorant as a topical application. [3] Colloidal Silver can also be used as a nasal spray in the nasal congestion problems. One of the main advantage of Colloidal Silver is, the microorganism never develop the resistance to the Colloidal Silver, as like the conventional broad and narrow spectrum antibiotics. [4] Because, the bacteria can develop resistance to any of the antibiotic drugs, but, the Colloidal Silver is not an antibiotic and hence the bacteria will not be able to develop a silver resistant gene.


1. Searle, A.B. “The use of colloids in health and disease”. (Quoting from the British Medical Journal, May 12, 1917) E.P. Dutton & Company: New York, 1919, p. 82.

2. Bechhold, H. “Colloids in biology and medicine”, translated by J.G.M. Bullow., D. Van Nostrand Company, New York, 1919, p. 367

3. Moyasar, T.Y.; Landeen, L.K.; Messina, M. C.; Kutz, S.M.; and Gerba, C.P. ” Disinfection of bacteria in water systems by using
electrolytically generated copper, silver and reduced levels of free chlorine”. Found in Canadian Journal of Microbiology. The National Research Council of Canada: Ottawa, Ont., Canada, 1919, pp. 109-116.

4. Thurman, R.B. and Gerba, C.P. “The molecular mechanisms of copper and silver ion disinfection of bacteria and viruses”. A paper presented in the First International Conference on Gold and Silver in Medicine. The Silver Institute: Washington, v. 18, 4, 1989, p. 295

Chlamydia pneumoniae – prevention strategies

It is better to prevent than cure the disease. This golden proverb is applicable for every disease, but it is more apt for the microbial organisms induced diseases. There are some preventive measures for the Chlamydia pneumoniae infections but the advantages are often limited and these measures can be effective for individuals and it is mostly ineffective for a community based epidemiological approach. Some of the preventive measures to avoid the Chlamydia pneumoniae infections are:

A. It is better to avoid the close quarters contact with the infected persons.

B. Avoiding social environments like shopping, parties and public gathering in the time of widespread outbreak events.

C. Avoiding cold environment which is the dwelling place for the Chlamydia pneumoniae and other similar influenza causing organisms.

D. Avoid smoking habits and even the incidence of passive smoking in home, office and public places. Smoking can increase the incidence of Chlamydia pneumoniae infection or tends to increase the disease progression, morbidity and mortality.

E. Giving influenza vaccines for the children with regular booster doses.

F. Apart from the above said preventive measures, personal hygiene is very important. This includes avoid touching nose and eyes frequently with hands, washing hands with disinfectants, wearing face masks, if you are infected.

G. Avoid taking antibiotics for the minor infections like common cold and irrational use of broad spectrum antibiotics and self medications like steroids which can suppress the immune system.

H. Once in a year, health check-ups that include the C-Reactive proteins, Complete blood counts, RA factor analysis may be helpful to diagnose the recent and asymptomatic infections.


Treatment for Chlamydia pneumoniae – Azithromycin

The current treatment option for the Chlamydia pneumoniae infection is the antibiotics which is similar as like a double-edged sword that needs utmost care to handle and in most of the incidence it is harmful to patient. Some of the common disadvantages of the antibiotic therapy for Chlamydia pneumoniae are the antibiotic resistance and its complications. Some of the conventional antibiotics that are used to treat the Chlamydia pneumoniae infections are Tetracycline, Azithromycin, Gatifloxacin, Ciprofloxacin, Clarithromycin, Rifampicin, Telithromycin, Erythromycin, Levofloxacin and Doxycycline etc. Most of the Physicians argue that the single drug therapy is better than the combined medicine regimens. However, it is not proved scientifically and the benefits of the combined regimen and the single drug therapy are yet to be confirmed by researchers. Each of these antibiotics has its own side effects and sometimes the patient may feel the infection is better than the side effects of the antibiotic treatment.

The main problem associated with the antibiotic therapy is the development of antibiotic resistant genes in the microorganisms that can complicate the treatment procedure and most of the time, even the broad spectrum antibiotics are not useful and the pathogen continue to thrive and replicate in the host’s body without any difficulty. In the recent medical trends, the antibiotic resistant organism pose a severe threat to the medical community and these cases are difficult to treat. The antibiotic resistance is not yet reported in the naturally occurring organisms but the antibiotic resistance is more common in the hospital-acquired infections. In Chlamydia pneumoniae infections, long term antibiotic treatments can cause antibiotic resistance in the humans, according to the research reports. In the untreated cases of Chlamydia pneumoniae infection, mostly the patient will die due to influenza and its complications.

Diagnostic tests for Chlamydia pneumoniae infestation/infection

The laboratory diagnosis available for the Chlamydia pneumoniae infections are:

i) Serological analysis

In the serological analysis, the Immunoglobulin-G (IgG) analysis is the very important diagnostic test that can be used to assess the presence and severity of the disease as well to predict the prognosis of the disease. This test is performed by using the microimmunofluorescence test. In case of the presence of Chlamydia pneumoniae infection, there will be a four fold increase in the titre values and this test is to be repeated at least two to three times, a month for the confirmation and for the reassessment. Other important tests for the Chlamydia pneumoniae infection is the C – reactive protein test. These are the commonly available diagnostic test for the confirmation of the Chlamydia pneumoniae infections.

ii) Polymerase Chain Reactions

The Polymerase Chain Reaction is a very promising diagnostic test that is uncommonly used in the hospital environment for the identification of the Chlamydia pneumoniae DNA in the clinical samples of throat, nose and buccal cavity swabs. The PCR is commonly employed in the research purpose and the availability for the routine analysis is rare in many countries. But the PCR is the confirmatory test for the Chlamydia pneumoniae infection.

iii) Cell cultures from oral or nasal swabs

The cell cultures analysis of the clinical samples like the nasal and oral swabs are confirmatory tests for the diagnostic purposes. But it is not commonly available in the hospitals and the diagnostic laboratories.

iv) Radiological examination

The radiological analysis of the chest for the confirmation of the Chlamydia pneumoniae infections is somewhat confirmatory and it is now in practice. The common findings are pleural effusion, bilateral interstitial infiltration of the lymphocytes and the neutrophil cells. This test must be clinical correlated with the Blood tests for to rule out the possibilities of other infections.

v) Other blood tests

Some of the laboratory blood tests that are useful for the identification of the Chlamydia pneumoniae are the Erythrocyte Sedimentation Rate (ESR), Complete blood count with differential leukocyte count and serum alkaline phosphatase. There is no absolute increase in the leukocyte count but an increase in alkaline phosphatase and the ESR.

Co-infections with other microbes and the preventive measures

The Chlamydia pneumoniae infections are usually accompanied by a number of co-infections that can rapidly progress the disease and deteriorate the treatment of the disease. Some of the co-infections of the Chlamydia pneumoniae infections are mycoplasma pneumoniae infection (Lyme’s disease), Brucella species infections, Streptococcal infections and other viral infections like Herpes Virus-6 and Epstein-Barr virus infections. The mixed infections are very difficult to treat as like the antibiotic resistant organisms. Mostly they will not respond to any of the broad spectrum antibiotics and will end up in the drug induced side effects. Around 50% of the Chlamydia pneumoniae infected peoples are reported with the mixed infections and most of these peoples opt for clinical trial new drugs than the existing antibiotics. Because they believe the new drugs can be effective. But in many of the situations, the new drugs are worse than the existing antibiotics, as the side effects of the new drugs are not reported by anyone before. When you are diagnosed with Chlamydia pneumoniae infections, it is better to diagnose the associated co-infections for the better treatment. If you are diagnosed positive for mixed infections, try to get a Physician’s advice and go for the regimen of antibiotics to treat the mixed infections. Never take other medicines or antibiotics which may worsen the situation.

Susceptibility to Chlamydia pneumoniae

The Chlamydia pneumoniae infection is most common in the young teen and the adults who had the infection in the early stages of their life. However, the normal people without the history of Chlamydia pneumoniae infection in the young age have 15 – 20% chances for the infection in their adult stages and the rest of the life. The people who have the habit of self-medications, mainly the steroids and antibiotics are more prone to Chlamydia pneumoniae infections and they are usually the Immuno-compromised individuals. The susceptibility of the Chlamydia pneumoniae infection is more in the patients with other co-infections like the cytomegalovirus, herpes virus, Human Immuno Virus infections and mycoplasma infections. The person with poor hygiene and medical staffs who carelessly handle the Chlamydia pneumoniae patients can acquire the infection in no time. The person who is a frequent smoker or having passive smoking can damage the respiratory immune system and they can get the Chlamydia pneumoniae infection very often than the non-smokers (active and passive smoking). If you suspect a person with Chlamydia pneumoniae infection or if the individual is a ‘confirmed’ patient, you need keep some distance and avoid close contacts with the person and his belongings, which are called as fomites.

Epidemiology and Seroprevalence of Chlamydia pneumoniae

According to the published reports in peer-reviewed medical journals, the Sero-prevalence of the Chlamydia pneumoniae infection is based on the community-acquired pneumonia. It varies from country to country and it mostly depends on the tropical and sub-tropical climates of the geographical locations. Apart from the geographical locations, the life style, food habits of the people in the different countries may contribute/influence the development of the Chlamydia pneumoniae infection. Although there is no relation between the gender distribution and race with the Chlamydia pneumoniae infection, it is common in the males (60 – 90%) and in the world, the white or the European and other Euro-American peoples are the mostly affected people in the world than the Negroes and the Asian populations. According to the World Health Organization report, the incidence of Chlamydia pneumoniae infection is high in the United States of America. The approximate or the estimated number of Chlamydia pneumoniae infected cases in the United States of America is around or more than 300,000 cases per year. The predominant cases of this Chlamydia pneumoniae infection is due to the Community Acquired pneumonia and the rate of estimated cause and the chances of the spread of the pathogen is around 10 – 20% which mainly infects the young adults and adults with the medical history of Chlamydia pneumoniae infection in their early age. In a research report published in the Journal Nature a meta-analysis of two research reports found that the incidence of community acquired pneumonia caused by the Chlamydia pneumoniae in 4337 patients was 8% and this is from the regions of North America only that includes the upper parts of the Central America and the Canada. Apart from this data, it is reported that there is an incidence ratio of at least 7% in all over the European countries, approximately 6% in the Latin American countries and just 5% in the continent of Asia. These results suggestive that may be due to the climatic conditions in the Western countries, which can promote the growth of Chlamydia pneumoniae infection than in the rest in the rest of the world and also the smoking habits in the young teens, adults and in elderly people without any gender variations. Though, Chlamydia pneumoniae infections occur in every country through the year, some of the recent epidemiological research studies reports that a 4-year and repetitive cycle in the incidence of Chlamydia pneumoniae is reported. Once in four years, there will be severe outbreak of the Chlamydia pneumoniae infections and many of the incidences will have an underlying aetiology of Community-acquired pneumonia and with other mixed bacterial and/or viral infections in the host.
The reason for the increased incidence of Chlamydia pneumoniae infections in the males is may be due to the smoking habits and their personal hygienic habits. The age is non-specific epidemiological factor and the initial stages of the Chlamydia pneumoniae infections are quite common in the people with the age group of 7- 40 years. The possibility of the recurrence of the Chlamydia pneumoniae infection is more common in elderly persons with smoking habits and in the people with weak immune system or with other mixed infections. In a meta-analysis of recent epidemiological report suggests that, about more than 50% of young adults, teen agers and 75% of the aged people with or without smoking habits have the medical history of a previous Chlamydia pneumoniae infection.

Symptoms and signs of Chlamydia pneumoniae

Most of the C. pneumoniae infections are asymptomatic in the initial stages of the infection. But as the disease progresses, the disease will become symptomatic and it develops in to a full blown disease. The symptoms of Chlamydia pneumoniae infection will include, but not limited to, the development bilateral interstitial infiltrates as evidenced by the chest x-ray imaging, persistent bronchitis and cough, development of bronchial sound at the time of breathing but there will be no sign of wheezing like symptoms, some of the rare symptoms like the peri-bronchial cuffing, increased respiratory rate due to the decreased pulmonary function and tidal volume, nasal congestion and respiratory distress that may some times lead to sudden respiratory arrest and even it can cause death. After the development of full-blown disease, the Chlamydia pneumoniae infection often causes other life threatening complications like the development of lung diseases, Acute Respiratory Distress Syndrome, Heart diseases like Myocarditis, Myocardial infarction and Stroke and other autoimmune diseases like Guillain-Barre syndrome. In the initial stages, the Chlamydia pneumoniae infection is treatable and curable. If left untreated, the later stage diseases and its complications are untreatable. Hence the prevention of the infection and disease is better than curing the disease.

A. Lung Diseases

One of the most common complications of Chlamydia pneumoniae infection is the Lung diseases. This complication usually starts after the symptomatic phase of the infection with an acute lower respiratory tract infection with marked Pharyngitis, persistent cough, flu like symptoms, mild to moderate drug responsive asthma, preliminary stages of Chronic Obstructive Pulmonary Disorder (COPD) with acute exacerbations. Many research findings are suggestive of the possible clinical links between the Chlamydia pneumoniae infection and the Sarcoidosis and even the pulmonary cancer. This is mainly due to the mixed infection with the organisms like Mycoplasma species and the Herpes Viruses. There will a gradual but irreversible decrease in the lung functions as evidenced by the decreased tidal volumes in the Pulmonary Function Tests. The incidences of the COPD and other lung diseases are increased in the association of smoking habits and the treatment of the disease is often impossible and also smoking can decrease the antigen identification of the macrophages that can kill and scavenge the damage cells including the bacteria and viruses. The chronic infection usually results in the inflammation of the associated as well the nearby tissues that may result in the development of the lung cancer. These complications are very common in the infected young teens and the adults with past medical history of Chlamydia pneumoniae infections. The other risk factors like the smoking, cold environment and existence of other immuno-compromising diseases can increase the incidence of these complications.

The exact underlying molecular mechanism of the Chlamydia pneumoniae is when the organism infects a human, the pathogen enters in to the lung cell and then it invades a white blood cell, as it an intracellular pathogen. Then it is very difficult for the immune system to identify the organism in the blood stream and the Chlamydia pneumoniae evades the immune mediated response. After this process, the Chlamydia pneumoniae enters in to the reproduction cycle and then it replicates inside the invaded cells. Then it can compromise the immune reactions and also there will be recurrence in the lung infection and episodic bronchial attacks. There will be a progressive increase in the secretion and release of Immunoglobulins like IgG, IgA and IgM. Most of these problems are unresponsive to the antibiotics and the antiviral drugs because, Chlamydia Pneumoniae is an intracellular pathogen that harbours inside the normal white blood cells. Some of the alternative and complimentary medicines can give promising effects with out the any damage to the host which is contrary the existing antibiotics. Some of the research reports claims that the person with Chlamydia pneumoniae infection can develop the disease of Cystic Fibrosis and vice-versa.

B. Heart and Circulatory Diseases

The next and important complication of the Chlamydia pneumoniae infection is the incidence of the heart diseases like Ischemia, myocardial infarction, myocarditis and even stroke. The Chlamydia pneumoniae is commonly called as the ‘Heart-Attack Germ’. The bacteria that invade the white blood cells enter the circulatory system from the pulmonary system by using invaded cells as a vehicle. These bacteria will be rapidly reproduced in the arteries that can cause the inflammation in the arteries that can cause bleeding and clotting reactions inside the blood vessels. By the pathophysiological process the cholesterol molecules are transported and become settled in the inflamed site and the inflammation can also cause the narrowing of the blood vessel walls. This can immediately results in the myocardial ischemia and then myocardial infarction which is popularly known as the ‘Heart Attack’. Many research findings suggest that the Chlamydia pneumoniae cells are present in the atherosclerotic plaques (macrophage laden LDL-foam cells) and the inflamed arterial tissue which confirmed the role of Chlamydia pneumoniae in the disease process and its progression. In the development of the stroke, the Chlamydia pneumoniae laden foam cells migrate to the distant arteries like the carotid arteries and they can block the blood circulation gradually. This can result in the development of the Atherosclerotic events which is also called as Stroke that will end up in death. Other biological markers like an increase in the Immunoglobulin – A (IgA) titres can implicate the association of the Chlamydia pneumoniae infection and the heart diseases. Some of the other causes that can contribute to the heart diseases like Myocarditis are the antigen and molecular mimicry. The antigenic structure of the bacterial cell walls and the biomolecules present in the bacterial cells are mostly similar to the heart cells, particularly the myocardial cells. This can elicit an immune response in the body that results in the damage of the myocardial cells that results in the inflammation and damage of the heart cells and eventually leads to death. There is a strong link between the smoking, hyperhomocystinemia, Sero-positive Chlamydial infection, Hypertension and the cardiovascular diseases. However, the antibiotics are not useful in the Chlamydia pneumoniae mediated cardiovascular events and the conventional treatment of cardiovascular diseases can treat the symptoms of the heart diseases but not the origin of the disease, the Chlamydia pneumoniae infection. Some of the new clinical trial studies suggest that the emergence of the new macrolide antibiotics is useful to some extent but still, they are under clinical research investigations.

C. Autoimmune disorders and other problems

The Chlamydia pneumoniae infection also causes other complications like localized or systemic autoimmune disorders like Rheumatoid Arthritis, Guillain-Barre syndrome, serum sickness etc. Apart from these problems, other medical conditions like Infertility, Alzheimer’s disease, immune system dysfunction and rarely eye diseases can occur.

The autoimmune disorders may be a localized or systemic disorder that is elicited by our own immune system against the body’s cell. The Chlamydia pneumoniae infections in an individual can cause autoimmune disorders like Rheumatoid arthritis and Guillain-Barre Syndrome. The Rheumatoid arthritis is a disorder in which the body produces antibody against the bone and joint cells. In this medical condition, the cellular mimicry between the Chlamydia pneumoniae cell structure and the bone and joint cells cause an immune system mediated inflammatory response that results in the progressive and degenerative condition called Rheumatoid arthritis. The Guillain-Barre Syndrome is also an autoimmune disorder in which the auto antibodies attack the nerve cells by mistake, as it shares the molecular mimicry between Chlamydia pneumoniae and nerve cells.

Other medical problems that are associated with the Chlamydia pneumoniae infections are infertility in male and females, Alzheimer’s disease and vision problems. The male infertility can be caused by Chlamydial prostatitis, urethral dysfunction, seminal vesicle block and damage, progressive inflammation and infection in vas deferens and cystitis. The female infertility can be caused by Tubal Factor infertility, in which the Chlamydia pneumoniae induced adhesion factors plays an important role in the infertility. In these cases, there are chances for recurrence and most of these cases are treated successfully. According to the recent published reports, the Chlamydia pneumoniae is directly linked to the development of Alzheimer’s disease by the circulating monocytes laden with the bacteria that in turn cause inflammation in the bulbar region of the brain and the hippocampus, which plays an important role in the memory and cognitive functions of brain. Rarely some of the eye related problems and difficult to smell problems are also reported which may be due to the damage of the olfactory neuroepithelial cells of the brain. These are the secondary complications of the Chlamydia pneumoniae infection that needs immediate medical attention and treatment.